Sara Davenport

Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

Andreas Schlicker, Garry Beran, Christine M. Chresta et al. · BMC Medical Genomics · 2012 · 257 citations · Full text

Medicine, Cancer Biology, Oncology +17

AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer

D. Mark Hickinson, Teresa Klinowska, Georgina Speake et al. · Clinical Cancer Research · 2010 · 120 citations

Medicine, Oncology, Pharmacology +17

Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines

Catherine Bardelle, Darren A.E. Cross, Sara Davenport et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Inhibitors of the tyrosine kinase EphB4. Part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines

Catherine Bardelle, Tanya Coleman, Darren A.E. Cross et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16